Global Urokinase Market Research Report 2020

Publisher Name :
Date: 03-Jan-2020
No. of pages: 97
Inquire Before Buying

Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.

The global Urokinase industry has a rather high concentration. The major manufacturers are concentrated in China, such as NDPharm, Wanhua Biochem, Jiangxi Haoran Bio-Pharma and Jiangsu Aidea Pharmaceutica. At present, NDPharm is the world leader, holding 62% production market share in 2016.

The global Urokinase market is valued at 37 million US$ in 2020 is expected to reach 57 million US$ by the end of 2026, growing at a CAGR of 6.1% during 2021-2026.

This report focuses on Urokinase volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Urokinase market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America and China. etc.

Market Segment Analysis

The research report includes specific segments by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2015 to 2026. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type, the Urokinase market is segmented into

- Urokinase Powder

- Urokinase Solution

- Urokinase powder captures about 93% of urokinase market in 2018.

Segment by Application

- Hospital

- Clinic

- Others

- Hospital accounts for nearly 80% of total downstream consumption of urokinase in global in 2018.

Global Urokinase Market: Regional Analysis

The Urokinase market is analysed and market size information is provided by regions (countries). The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type and by Application segment in terms of sales and revenue for the period 2015-2026.

The key regions covered in the Urokinase market report are:

North America

- U.S.

- Canada

Europe

- Germany

- France

- U.K.

- Italy

- Russia

Asia-Pacific

- China

- Japan

- South Korea

- India

- Australia

- Taiwan

- Indonesia

- Thailand

- Malaysia

- Philippines

- Vietnam

Latin America

- Mexico

- Brazil

- Argentina

Middle East & Africa

- Turkey

- Saudi Arabia

- U.A.E

Global Urokinase Market: Competitive Analysis

This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, the global price of manufacturers, and sales by manufacturers during the forecast period of 2015 to 2019.

The major players in global Urokinase market include:

- NDPHARM

- Wanhua Biochem

- Jiangxi Haoran Bio-Pharma

- Jiangsu Aidea Pharmaceutical

- Techpool

- Microbic Biosystems Inc

- LIVZON

Global Urokinase Market Research Report 2020

Table of Contents
1 Urokinase Market Overview
1.1 Product Overview and Scope of Urokinase
1.2 Urokinase Segment by Type
1.2.1 Global Urokinase Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Urokinase Powder
1.2.3 Urokinase Solution
1.3 Urokinase Segment by Application
1.3.1 Urokinase Sales Comparison by Application: 2020 VS 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Urokinase Market Size Estimates and Forecasts
1.4.1 Global Urokinase Revenue 2015-2026
1.4.2 Global Urokinase Sales 2015-2026
1.4.3 Urokinase Market Size by Region: 2020 Versus 2026
2 Global Urokinase Market Competition by Manufacturers
2.1 Global Urokinase Sales Market Share by Manufacturers (2015-2020)
2.2 Global Urokinase Revenue Share by Manufacturers (2015-2020)
2.3 Global Urokinase Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Urokinase Manufacturing Sites, Area Served, Product Type
2.5 Urokinase Market Competitive Situation and Trends
2.5.1 Urokinase Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Urokinase Players (Opinion Leaders)
3 Urokinase Retrospective Market Scenario by Region
3.1 Global Urokinase Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Urokinase Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Urokinase Market Facts & Figures by Country
3.3.1 North America Urokinase Sales by Country
3.3.2 North America Urokinase Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Urokinase Market Facts & Figures by Country
3.4.1 Europe Urokinase Sales by Country
3.4.2 Europe Urokinase Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Urokinase Market Facts & Figures by Region
3.5.1 Asia Pacific Urokinase Sales by Region
3.5.2 Asia Pacific Urokinase Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Urokinase Market Facts & Figures by Country
3.6.1 Latin America Urokinase Sales by Country
3.6.2 Latin America Urokinase Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Urokinase Market Facts & Figures by Country
3.7.1 Middle East and Africa Urokinase Sales by Country
3.7.2 Middle East and Africa Urokinase Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Urokinase Historic Market Analysis by Type
4.1 Global Urokinase Sales Market Share by Type (2015-2020)
4.2 Global Urokinase Revenue Market Share by Type (2015-2020)
4.3 Global Urokinase Price Market Share by Type (2015-2020)
4.4 Global Urokinase Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Urokinase Historic Market Analysis by Application
5.1 Global Urokinase Sales Market Share by Application (2015-2020)
5.2 Global Urokinase Revenue Market Share by Application (2015-2020)
5.3 Global Urokinase Price by Application (2015-2020)
6 Company Profiles and Key Figures in Urokinase Business
6.1 NDPHARM
6.1.1 Corporation Information
6.1.2 NDPHARM Description, Business Overview and Total Revenue
6.1.3 NDPHARM Urokinase Sales, Revenue and Gross Margin (2015-2020)
6.1.4 NDPHARM Products Offered
6.1.5 NDPHARM Recent Development
6.2 Wanhua Biochem
6.2.1 Wanhua Biochem Urokinase Production Sites and Area Served
6.2.2 Wanhua Biochem Description, Business Overview and Total Revenue
6.2.3 Wanhua Biochem Urokinase Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Wanhua Biochem Products Offered
6.2.5 Wanhua Biochem Recent Development
6.3 Jiangxi Haoran Bio-Pharma
6.3.1 Jiangxi Haoran Bio-Pharma Urokinase Production Sites and Area Served
6.3.2 Jiangxi Haoran Bio-Pharma Description, Business Overview and Total Revenue
6.3.3 Jiangxi Haoran Bio-Pharma Urokinase Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Jiangxi Haoran Bio-Pharma Products Offered
6.3.5 Jiangxi Haoran Bio-Pharma Recent Development
6.4 Jiangsu Aidea Pharmaceutical
6.4.1 Jiangsu Aidea Pharmaceutical Urokinase Production Sites and Area Served
6.4.2 Jiangsu Aidea Pharmaceutical Description, Business Overview and Total Revenue
6.4.3 Jiangsu Aidea Pharmaceutical Urokinase Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Jiangsu Aidea Pharmaceutical Products Offered
6.4.5 Jiangsu Aidea Pharmaceutical Recent Development
6.5 Techpool
6.5.1 Techpool Urokinase Production Sites and Area Served
6.5.2 Techpool Description, Business Overview and Total Revenue
6.5.3 Techpool Urokinase Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Techpool Products Offered
6.5.5 Techpool Recent Development
6.6 Microbic Biosystems Inc
6.6.1 Microbic Biosystems Inc Urokinase Production Sites and Area Served
6.6.2 Microbic Biosystems Inc Description, Business Overview and Total Revenue
6.6.3 Microbic Biosystems Inc Urokinase Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Microbic Biosystems Inc Products Offered
6.6.5 Microbic Biosystems Inc Recent Development
6.7 LIVZON
6.6.1 LIVZON Urokinase Production Sites and Area Served
6.6.2 LIVZON Description, Business Overview and Total Revenue
6.6.3 LIVZON Urokinase Sales, Revenue and Gross Margin (2015-2020)
6.4.4 LIVZON Products Offered
6.7.5 LIVZON Recent Development
7 Urokinase Manufacturing Cost Analysis
7.1 Urokinase Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Urokinase
7.4 Urokinase Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Urokinase Distributors List
8.3 Urokinase Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Urokinase Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Urokinase by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Urokinase by Type (2021-2026)
10.2 Urokinase Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Urokinase by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Urokinase by Application (2021-2026)
10.3 Urokinase Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Urokinase by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Urokinase by Region (2021-2026)
10.4 North America Urokinase Estimates and Projections (2021-2026)
10.5 Europe Urokinase Estimates and Projections (2021-2026)
10.6 Asia Pacific Urokinase Estimates and Projections (2021-2026)
10.7 Latin America Urokinase Estimates and Projections (2021-2026)
10.8 Middle East and Africa Urokinase Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Urokinase Sales (M IU) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Urokinase Sales (M IU) Comparison by Application: 2020 VS 2026
Table 3. Global Urokinase Market Size by Type (M IU) (US$ Million) (2020 VS 2026)
Table 4. Global Key Urokinase Manufacturers Covered in This Study
Table 5. Global Urokinase Sales (M IU) by Manufacturers (2015-2020)
Table 6. Global Urokinase Sales Share by Manufacturers (2015-2020)
Table 7. Global Urokinase Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Urokinase Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Urokinase Average Price (USD/M IU) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Urokinase Sales Sites and Area Served
Table 11. Manufacturers Urokinase Product Types
Table 12. Global Urokinase Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Urokinase by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Urokinase as of 2019)
Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Urokinase Players
Table 16. Global Urokinase Sales (M IU) by Region (2015-2020)
Table 17. Global Urokinase Sales Market Share by Region (2015-2020)
Table 18. Global Urokinase Revenue (Million US$) by Region (2015-2020)
Table 19. Global Urokinase Revenue Market Share by Region (2015-2020)
Table 20. North America Urokinase Sales by Country (2015-2020) (M IU)
Table 21. North America Urokinase Sales Market Share by Country (2015-2020)
Table 22. North America Urokinase Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Urokinase Revenue Market Share by Country (2015-2020)
Table 24. Europe Urokinase Sales by Country (2015-2020) (M IU)
Table 25. Europe Urokinase Sales Market Share by Country (2015-2020)
Table 26. Europe Urokinase Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Urokinase Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Urokinase Sales by Region (2015-2020) (M IU)
Table 29. Asia Pacific Urokinase Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Urokinase Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Urokinase Revenue Market Share by Region (2015-2020)
Table 32. Latin America Urokinase Sales by Country (2015-2020) (M IU)
Table 33. Latin America Urokinase Sales Market Share by Country (2015-2020)
Table 34. Latin America Urokinase Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Urokinase Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Urokinase Sales by Country (2015-2020) (M IU)
Table 37. Middle East and Africa Urokinase Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Urokinase Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Urokinase Revenue Market Share by Country (2015-2020)
Table 40. Global Urokinase Sales (M IU) by Type (2015-2020)
Table 41. Global Urokinase Sales Share by Type (2015-2020)
Table 42. Global Urokinase Revenue (Million US$) by Type (2015-2020)
Table 43. Global Urokinase Revenue Share by Type (2015-2020)
Table 44. Global Urokinase Price (USD/M IU) by Type (2015-2020)
Table 45. Global Urokinase Sales (M IU) by Application (2015-2020)
Table 46. Global Urokinase Sales Market Share by Application (2015-2020)
Table 47. Global Urokinase Sales Growth Rate by Application (2015-2020)
Table 48. NDPHARM Urokinase Corporation Information
Table 49. NDPHARM Description and Business Overview
Table 50. NDPHARM Urokinase Sales (M IU), Revenue (Million US$), Price (USD/M IU) and Gross Margin (2015-2020)
Table 51. NDPHARM Main Product
Table 52. NDPHARM Recent Development
Table 53. Wanhua Biochem Urokinase Corporation Information
Table 54. Wanhua Biochem Corporation Information
Table 55. Wanhua Biochem Urokinase Sales (M IU), Revenue (Million US$), Price (USD/M IU) and Gross Margin (2015-2020)
Table 56. Wanhua Biochem Main Product
Table 57. Wanhua Biochem Recent Development
Table 58. Jiangxi Haoran Bio-Pharma Urokinase Corporation Information
Table 59. Jiangxi Haoran Bio-Pharma Corporation Information
Table 60. Jiangxi Haoran Bio-Pharma Urokinase Sales (M IU), Revenue (Million US$), Price (USD/M IU) and Gross Margin (2015-2020)
Table 61. Jiangxi Haoran Bio-Pharma Main Product
Table 62. Jiangxi Haoran Bio-Pharma Recent Development
Table 63. Jiangsu Aidea Pharmaceutical Urokinase Corporation Information
Table 64. Jiangsu Aidea Pharmaceutical Corporation Information
Table 65. Jiangsu Aidea Pharmaceutical Urokinase Sales (M IU), Revenue (Million US$), Price (USD/M IU) and Gross Margin (2015-2020)
Table 66. Jiangsu Aidea Pharmaceutical Main Product
Table 67. Jiangsu Aidea Pharmaceutical Recent Development
Table 68. Techpool Urokinase Corporation Information
Table 69. Techpool Corporation Information
Table 70. Techpool Urokinase Sales (M IU), Revenue (Million US$), Price (USD/M IU) and Gross Margin (2015-2020)
Table 71. Techpool Main Product
Table 72. Techpool Recent Development
Table 73. Microbic Biosystems Inc Urokinase Corporation Information
Table 74. Microbic Biosystems Inc Corporation Information
Table 75. Microbic Biosystems Inc Urokinase Sales (M IU), Revenue (Million US$), Price (USD/M IU) and Gross Margin (2015-2020)
Table 76. Microbic Biosystems Inc Main Product
Table 77. Microbic Biosystems Inc Recent Development
Table 78. LIVZON Urokinase Corporation Information
Table 79. LIVZON Corporation Information
Table 80. LIVZON Urokinase Sales (M IU), Revenue (Million US$), Price (USD/M IU) and Gross Margin (2015-2020)
Table 81. LIVZON Main Product
Table 82. LIVZON Recent Development
Table 83. Sales Base and Market Concentration Rate of Raw Material
Table 84. Key Suppliers of Raw Materials
Table 85. Urokinase Distributors List
Table 86. Urokinase Customers List
Table 87. Market Key Trends
Table 88. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 89. Key Challenges
Table 90. Global Urokinase Sales (M IU) Forecast by Type (2021-2026)
Table 91. Global Urokinase Sales Market Share Forecast by Type (2021-2026)
Table 92. Global Urokinase Revenue (Million US$) Forecast by Type (2021-2026)
Table 93. Global Urokinase Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 94. Global Urokinase Sales (M IU) Forecast by Application (2021-2026)
Table 95. Global Urokinase Revenue (Million US$) Forecast by Application (2021-2026)
Table 96. Global Urokinase Sales (M IU) Forecast by Region (2021-2026)
Table 97. Global Urokinase Sales Market Share Forecast by Region (2021-2026)
Table 98. Global Urokinase Revenue Forecast by Region (2021-2026) (US$ Million)
Table 99. Global Urokinase Revenue Market Share Forecast by Region (2021-2026)
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Urokinase
Figure 2. Global Urokinase Sales Market Share by Type: 2020 VS 2026
Figure 3. Urokinase Powder Product Picture
Figure 4. Urokinase Solution Product Picture
Figure 5. Global Urokinase Consumption Market Share by Application: 2020 VS 2026
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Others
Figure 9. Global Urokinase Market Size 2015-2026 (US$ Million)
Figure 10. Global Urokinase Sales Capacity (M IU) (2015-2026)
Figure 11. Global Urokinase Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Urokinase Sales Share by Manufacturers in 2020
Figure 13. Global Urokinase Revenue Share by Manufacturers in 2019
Figure 14. The Global 5 and 10 Largest Players: Market Share by Urokinase Revenue in 2019
Figure 15. Urokinase Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 16. Global Urokinase Sales Market Share by Region (2015-2020)
Figure 17. Global Urokinase Sales Market Share by Region in 2019
Figure 18. Global Urokinase Revenue Market Share by Region (2015-2020)
Figure 19. Global Urokinase Revenue Market Share by Region in 2019
Figure 20. North America Urokinase Sales Market Share by Country in 2019
Figure 21. North America Urokinase Revenue Market Share by Country in 2019
Figure 22. U.S. Urokinase Sales Growth Rate (2015-2020) (M IU)
Figure 23. U.S. Urokinase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 24. Canada Urokinase Sales Growth Rate (2015-2020) (M IU)
Figure 25. Canada Urokinase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Europe Urokinase Sales Market Share by Country in 2019
Figure 27. Europe Urokinase Revenue Market Share by Country in 2019
Figure 28. Germany Urokinase Sales Growth Rate (2015-2020) (M IU)
Figure 29. Germany Urokinase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 30. France Urokinase Sales Growth Rate (2015-2020) (M IU)
Figure 31. France Urokinase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. U.K. Urokinase Sales Growth Rate (2015-2020) (M IU)
Figure 33. U.K. Urokinase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Italy Urokinase Sales Growth Rate (2015-2020) (M IU)
Figure 35. Italy Urokinase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Russia Urokinase Sales Growth Rate (2015-2020) (M IU)
Figure 37. Russia Urokinase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Asia Pacific Urokinase Sales Market Share by Region in 2019
Figure 39. Asia Pacific Urokinase Revenue Market Share by Region in 2019
Figure 40. China Urokinase Sales Growth Rate (2015-2020) (M IU)
Figure 41. China Urokinase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Japan Urokinase Sales Growth Rate (2015-2020) (M IU)
Figure 43. Japan Urokinase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. South Korea Urokinase Sales Growth Rate (2015-2020) (M IU)
Figure 45. South Korea Urokinase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. India Urokinase Sales Growth Rate (2015-2020) (M IU)
Figure 47. India Urokinase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Australia Urokinase Sales Growth Rate (2015-2020) (M IU)
Figure 49. Australia Urokinase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Taiwan Urokinase Sales Growth Rate (2015-2020) (M IU)
Figure 51. Taiwan Urokinase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Indonesia Urokinase Sales Growth Rate (2015-2020) (M IU)
Figure 53. Indonesia Urokinase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Thailand Urokinase Sales Growth Rate (2015-2020) (M IU)
Figure 55. Thailand Urokinase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Malaysia Urokinase Sales Growth Rate (2015-2020) (M IU)
Figure 57. Malaysia Urokinase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Philippines Urokinase Sales Growth Rate (2015-2020) (M IU)
Figure 59. Philippines Urokinase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Vietnam Urokinase Sales Growth Rate (2015-2020) (M IU)
Figure 61. Vietnam Urokinase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Latin America Urokinase Sales Market Share by Country in 2019
Figure 63. Latin America Urokinase Revenue Market Share by Country in 2019
Figure 64. Mexico Urokinase Sales Growth Rate (2015-2020) (M IU)
Figure 65. Mexico Urokinase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Brazil Urokinase Sales Growth Rate (2015-2020) (M IU)
Figure 67. Brazil Urokinase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Argentina Urokinase Sales Growth Rate (2015-2020) (M IU)
Figure 69. Argentina Urokinase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Middle East and Africa Urokinase Sales Market Share by Country in 2019
Figure 71. Middle East and Africa Urokinase Revenue Market Share by Country in 2019
Figure 72. Turkey Urokinase Sales Growth Rate (2015-2020) (M IU)
Figure 73. Turkey Urokinase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Saudi Arabia Urokinase Sales Growth Rate (2015-2020) (M IU)
Figure 75. Saudi Arabia Urokinase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. U.A.E Urokinase Sales Growth Rate (2015-2020) (M IU)
Figure 77. U.A.E Urokinase Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Sales Market Share of Urokinase by Type (2015-2020)
Figure 79. Sales Market Share of Urokinase by Type in 2019
Figure 80. Revenue Share of Urokinase by Type (2015-2020)
Figure 81. Revenue Market Share of Urokinase by Type in 2019
Figure 82. Global Urokinase Sales Growth by Type (2015-2020) (M IU)
Figure 83. Global Urokinase Sales Market Share by Application (2015-2020)
Figure 84. Global Urokinase Sales Market Share by Application in 2019
Figure 85. Global Revenue Share of Urokinase by Application (2015-2020)
Figure 86. Global Revenue Share of Urokinase by Application in 2020
Figure 87. NDPHARM Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Wanhua Biochem Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Jiangxi Haoran Bio-Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Jiangsu Aidea Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Techpool Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Microbic Biosystems Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. LIVZON Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. Price Trend of Key Raw Materials
Figure 95. Manufacturing Cost Structure of Urokinase
Figure 96. Manufacturing Process Analysis of Urokinase
Figure 97. Urokinase Industrial Chain Analysis
Figure 98. Channels of Distribution
Figure 99. Distributors Profiles
Figure 100. Porter's Five Forces Analysis
Figure 101. North America Urokinase Sales (M IU) and Growth Rate Forecast (2021-2026)
Figure 102. North America Urokinase Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 103. Europe Urokinase Sales (M IU) and Growth Rate Forecast (2021-2026)
Figure 104. Europe Urokinase Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 105. Latin America Urokinase Sales (M IU) and Growth Rate Forecast (2021-2026)
Figure 106. Latin America Urokinase Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 107. Middle East and Africa Urokinase Sales (M IU) and Growth Rate Forecast (2021-2026)
Figure 108. Middle East and Africa Urokinase Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 109. Asia Pacific Urokinase Sales (M IU) and Growth Rate Forecast (2021-2026)
Figure 110. Asia Pacific Urokinase Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 111. Bottom-up and Top-down Approaches for This Report
Figure 112. Data Triangulation
Figure 113. Key Executives Interviewed
  • Global Metabolism Drugs Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    Published: 08-Jan-2020        Price: US 3480 Onwards        Pages: 106
    Summary Market Overview The global Metabolism Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.1% in the forecast period of 2020 to 2025 and will expected to reach USD 18250 million by 2025, from USD 14970 million in 2019. The Metabolism Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landsca......
  • Global Levothyroxine Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    Published: 08-Jan-2020        Price: US 3480 Onwards        Pages: 105
    Summary Market Overview The global Levothyroxine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Levothyroxine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales ana......
  • Global Simethicone Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    Published: 06-Jan-2020        Price: US 3480 Onwards        Pages: 104
    Summary Market Overview The global Simethicone market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 1.3% in the forecast period of 2020 to 2025 and will expected to reach USD 31 million by 2025, from USD 29 million in 2019. The Simethicone market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analys......
  • Global Drugs for Schistosomiasis Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025
    Published: 03-Jan-2020        Price: US 3480 Onwards        Pages: 105
    Summary Market Overview The global Drugs for Schistosomiasis market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.6% in the forecast period of 2020 to 2025 and will expected to reach USD 90 million by 2025, from USD 78 million in 2019. The Drugs for Schistosomiasis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competi......
  • Global Deferiprone Market Research Report 2020
    Published: 03-Jan-2020        Price: US 2900 Onwards        Pages: 96
    Deferiprone is an orally bioavailable bidentate ligand with iron chelating activity.1 It binds to iron in a 3:1 (ligand:iron) molar ratio and, thereby, is able to remove excess iron from the body. Deferiprone has been investigated for clinical use in diseases of systemic iron overload. The proportion of deferiprone tablet in 2016 is about 62.64%, while deferiprone capsule have a 26.76% market share.Deferiprone is widely applied in Transfusional Iron Overload and NTDT Caused Iron Overload.......
  • Global Deferasirox Market Research Report 2020
    Published: 03-Jan-2020        Price: US 2900 Onwards        Pages: 92
    Deferasirox is an oral iron chelator. Its main use is to reduce chronic iron overload in patients who are receiving long-term blood transfusions for conditions such as beta- thalassemia and other chronic anemias. The half-life of deferasirox is between 8 and 16 hours allowing once a day dosing. Two molecules of deferasirox are capable of binding to 1 atom of iron which is subsequently eliminated by fecal excretion. Its low molecular weight and high lipophilicity allows the drug to be take......
  • Global Legal Marijuana Market Research Report 2020
    Published: 03-Jan-2020        Price: US 2900 Onwards        Pages: 93
    Marijuana is one of the most abused drugs in the world. The commercial marijuana industry exists on a state-by-state basis, and all medical and recreational programs are technically in violation of federal drug laws. The U.S. Department of Justice issued some guidelines in recent years that helped the marijuana industry gain traction, but these are not legally binding and could theoretically be nullified at any time. A medicinal cannabis product refers to a product which includes c......
  • Global Flu Vaccine Market Research Report 2020
    Published: 03-Jan-2020        Price: US 2900 Onwards        Pages: 119
    Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them. The classification of Flu Vaccine includes Who......
  • Global Rabies Vaccine Market Research Report 2020
    Published: 03-Jan-2020        Price: US 2900 Onwards        Pages: 96
    Rabies vaccine is an active immunizing agent used to prevent infection caused by the rabies virus. The vaccine works by causing your body to produce its own protection (antibodies) against the rabies virus. Every year more than 5.5 million people have died for rabies, mostly in Asia and Africa. With the implementation of China's two-child policy, downstream demand for rabies vaccine will not decrease in the coming few years. Rabies vaccine is an irreplaceable product, so profile of......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs